This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cannabis Dependence
and you are
between 18 and 50
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to to demonstrate the feasibility and tolerability of the use of Sativex in cannabis dependent individuals and to assess the effects of fixed or self titrated dosages of SATIVEX® (Δ9-tetrahydrocannabinol /cannabidiol combination in a buccal spray) on withdrawal symptoms, craving scores and cannabis consumption during the study period.

Provided treatments

  • Drug: Sativex
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01748799. The sponsor of the trial is Centre for Addiction and Mental Health and it is looking for 16 volunteers for the current phase.
Official trial title:
Effects of Fixed or Self-Titrated Dosages of Sativex on Cannabis Users